nach oben

Erschienen in:

2013 | OriginalPaper | Buchkapitel

11. Design of Nonhypertensive Conjugated Hemoglobins as Novel Resuscitation Fluids

verfasst von : Seetharama A. Acharya, Marcos Intaglietta, Amy G. Tsai, Fantao Meng

Erschienen in: Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics

Verlag: Springer Berlin Heidelberg

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Enhancing the molecular size/volume Hb was introduced, as a simple molecular approach to overcome or attenuate the extravasation mediated NO scavenging activity of Hb in vivo. Conjugation of Hb, as a chemical tool to achieve this objective, has now advanced beyond this initial concept. It requires us now to recognize that engineering of resuscitation fluids like properties to Hb is a novel concept and simple approach to neutralize/attenuate the in vivo hypertensive activity of acellular Hb. Development of conjugated hemoglobins is reviewed here as it lead to the development of this concept along with future perspectives. Extension Arm chemistry, that integrates the concepts of click chemistry into the various conjugation approaches of relevance to this aspect of blood substitute research is discussed. Bridging these approaches to increase the efficacy of engineering resuscitation fluid like properties to Hb is suggested as the future direction of designing conjugated Hbs as oxygen therapeutics. The integration of site directed mutagenesis to tame the molecular properties of Hb with the extension arm facilitated PEGylation to attenuate the impact of conjugation chemistry and/or conjugated polymer on the tertiary/quaternary structure of the Hb molecule is discussed in detail as applied to PEGylation of Hb as the conjugation approach of choice to generate nonhypertensive Hb as oxygen therapeutics. We conclude that such a synergistic approach will result in the attenuation of heme degradation product dependent and oxidative stress mediated in vivo toxicity as well as facilitating an increase in the oxygen delivering capacity of the conjugated Hb.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel HBOCs from Chemical Modification of Hb

Nächstes Kapitel Cellular-Type Hemoglobin-Based Oxygen Carriers to Mimic the Red Blood Cell Structure

Abuchowski A, van Es T, Palczuk NC, Davis FF (1977) Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J Biol Chem 252(11):3578–3581

Abuchowski A, Davis FF (1979) Preparation and properties of polyethylene glycol-trypsin adducts. Biochim Biophys Acta 578(1):41–46

Acharya AS, Manjula BN, Smith PK (1996) Hemoglobin crosslinkers. US Patent 5, 585, 484

Acharya AS, Manjula BN, Smith PK (1998) Hemoglobin crosslinkers. US Patent 5,750,725

Acharya AS, Manjula BN, Smith PK (2000) Hemoglobin crosslinkers, US patent 6, 017, 943

Acharya SA, Friedman JM, Manjula BN, Intaglietta M, Tsai AG, Winslow RM, Malavalli A, Vandegriff K, Smith PK (2005) Enhanced molecular volume of conservatively pegylated Hb: (SP-PEG5 K)6-HbA is non-hypertensive. Artif Cells Blood Substit Immobil Biotechnol 33(3):239–255

Acharya AS, Manjula BN (2006) Size enhanced hemoglobins: surface decoration and crosslinking of the protein with polyoxy alkylene glycols US patent 7, 019, 117

Acharya AS, Manjula BN (2007) Size enhanced hemoglobins: surface decoration and crosslinking of the protein with polyoxy alkylene glycols. US Patent 7,169,900

Acharya SA, Acharya VN, Kanika ND, Tsai AG, Intaglietta M, Manjula BN (2007a) Non-hypertensive tetraPEGylated canine haemoglobin: correlation between PEGylation, O2 affinity and tissue oxygenation. Biochem J 405(3):503–511

Acharya SA, Intaglietta M, Tsai AG (2007b) Modulation of the polyethylene glycol-hemoglobin structure to increase the efficiency of plasma expansion and O₂ carrying capacity. Trans Altern Trans Med 9(4):254–264

Acharya SA, Intaglietta M, Tsai AG, Ananda K, Meng F (2011) Design of novel PEGylated hemoglobins as oxygen-carrying plasma expanders: Engineering the structure of PEG-Hb adducts for supraperfusion. In: Bettati S, Mozzarelli A (eds) Chemistry and biochemistry of oxygen therapeutics: from transfusion to artificial blood.Wiley, New Jersey, pp 345–369

Acharya SA, Acharya VN, Meng FT, Ananda K, Tsai AG, Cantrill A, Intaglietta M (2011) Molecular aspects of in vivo “active supra perfusion” by P5K6 Alb and P5K6 Hb: Deformabilty of PEG-Protein and its potential role in enhancing perfusion Abstracts from 2011 XIII International Symposium on Blood Substitutes and Oxygen Therapeutics Boston, Massachusette, pp. 27–29

Acharya VN, Ananda K, Meng FT, Intaglietta M, Acharya SA (2011) Nonconservative EAF-PEGylation of albumin: conjugation chemistry influences structure of protein core and has no influence on PEG-shell packing density. In: Abstracts from 2011 XIII international symposium on blood substitutes and oxygen therapeutics Boston, Massachusette, pp. 27–29

Adachi K, Rappaport E, Eck HS, Konitzer P, Kim J, Surrey S (1991) Polymerization and solubility of recombinant hemoglobins α2β2(6Val) (Hb S) and α2β2(6Leu) (Hb Leu). Hemoglobin 15(5):417–430

Agishi T, Funakoshi Y, Honda H, Yamagata K, Kobayashi M, Takahashi M (1988) (Pyridoxylated hemoglobin)-(polyoxyethylene) conjugate solution as blood substitute for normothermic whole body rinse-out. Biomater Artif Cells Artif Organs 16(1–3):261–270

Alayash AI (2010) Setbacks in blood substitutes research and development: a biochemical perspective. Clin Lab Med 30(2):381–389

Ananda K, Manjula BN, Meng F, Acharya VN, Intaglietta M, Acharya SA (2012) Packing density of the PEG-shell in PEG-albumins: PEGylation induced viscosity and COP is inverse correlate of packing density. Artif Cells Blood Substit Immobil Biotechnol 40(1–2):14–27

Bakker JC, Berbers GA, Bleeker WK, den Boer PJ, Biessels PT (1992) Preparation and characterization of crosslinked and polymerized hemoglobin solutions. Biomater Artif Cells Immobilization Biotechnol 20(2–4):233–241

Baldwin AL, Chien S (1988) Effect of dextran 40 on endothelial binding and vesicle loading of ferritin in rabbit aorta. Arteriosclerosis 8(2):140–146

Benesch R, Benesch RE (1981) Preparation and properties of hemoglobin modified with derivatives of pyridoxal. Methods Enzymol 76:147–159

Berbers GA, Bleeker WK, Stekkinger P, Agterberg J, Rigter G, Bakker JC (1991) Biophysical characteristics of hemoglobin intramolecularly cross-linked and polymerized. J Lab Clin Med 117(2):157–165

Bobofchak KM, Mito T, Texel SJ, Bellelli A, Nemoto M, Traystman RJ, Koehler RC, Brinigar WS, Fronticelli C (2003) A recombinant polymeric hemoglobin with conformational, functional, and physiological characteristics of an in vivo O2 transporter. Am J Physiol Heart Circ Physiol 285(2):H549–H561

Bonneaux F, Labrude P, Dellacherie E (1981) Preparation and oxygen binding properties of soluble covalent hemoglobin-dextran conjugates. Experientia 37(8):884–886

Bonneaux F, Dellacherie E (1995) Fixation of various aldehydic dextrans onto human hemoglobin: study of conjugate stability. J Protein Chem 14(1):1–5

Bradley R, Sloshberg S, Nho K, Czuba B, Szesko D, Shorr R (1994) Production of PEG-modified bovine hemoglobin: economics and feasibility. Artif Cells Blood Substit Immobil Biotechnol 22(3):657–667

Bucci E, Razynska A, Kwansa H, Matheson-Urbaitis B, O’Hearne M, Ulatowski JA, Koehler RC (1996a) Production and characteristics of an infusible oxygen-carrying fluid based on hemoglobin intramolecularly cross-linked with sebacic acid. J Lab ClinMed 28(2):146–153

Bucci E, Razynska A, Kwansa H, Matheson-Urbaitis B, O’Hearne M, Ulatowski JA, Koehler RC (1996b) Production and characteristics of an infusible oxygen-carrying fluid based on hemoglobin intramolecularly cross-linked with sebacic acid. J Lab Clin Med 128(2):146–153

Buehler PW, Mehendale S, Wang H, Xie J, Ma L, Trimble CE, Hsia CJ, Gulati A (2000) Resuscitative effects of polynitroxylated αα-cross-linked hemoglobin following severe hemorrhage in the rat. Free Radic Biol Med 29(8):764–774

Buehler PW, Boykins RA, Norris S, Alayash AI (2006) Chemical characterization of diaspirin cross-linked hemoglobin polymerized with poly (ethylene glycol). Anal Chem 78(13):4634–4641

Buehler PW, Alayash AI (2008) All hemoglobin-based oxygen carriers are not created equally. Biochim Biophys Acta 1784(10):1378–1381

Bunn HF, Esham WT, Bull RW (1969) The renal handling of hemoglobin I. Glomerular filtration. J Exp Med 129(5):909–923

Cabrales P, Tsai AG, Intaglietta M (2004) Microvascular pressure and functional capillary density in extreme hemodilution with low- and high-viscosity dextran and a low-viscosity Hb-based O2 carrier. Am J Physiol Heart Circ Physiol 287(1):H363–H373

Cabrales P, Tsai AG, Intaglietta M (2007) Resuscitation from emorrhagic shock with hydroxyethyl starch and coagulation changes. Shock 28(4):461–467

Cabrales P, Tsai AG, Intaglietta M (2008) Increased plasma viscosity prolongs icrohemodynamic conditions during small volume resuscitation from hemorrhagic shock. Resuscitation 77(3):379–386

Cabrales P, Friedman JM. HBOC vasoactivity: Interplay between nitric oxide scavenging and capacity to generate bioactive nitric oxide species. Antioxid Redox Signal. 2013 Feb 12 [Epub ahead of print]

Caccia D, Ronda L, Frassi R, Perrella M, Del Favero E, Bruno S, Pioselli B, Abbruzzetti S, Viappiani C, Mozzarelli A (2009) PEGylation promotes hemoglobin tetramer dissociation. Bioconjug Chem 20(7):1356–1366

Chang TMS (1964) Semipermeable microcapsules. Science 146:524

Chang TMS (1971) Stabilization of enzyme by microencapsulation with a concentrated protein solution or by crosslinking with glutaraldehyde. Biochem Biophys Res Com 44:1531–1533

Chang JE, Wong JT (1977) Synthesis of soluble dextran-hemoglobin complexes of different molecular sizes. Can J Biochem 55(4):398–403

Chen JY, Scerbo M, Kramer G (2009) A review of blood substitutes: examining the history, clinical trial results, and ethics of Hemoglobin-based oxygen carriers. Clinics (Sao Paulo) 64(8):803–813

Cole RH, Vandegriff KD (2011) MP4, a vasodilatory PEGylated hemoglobin. Adv Exp Med Biol 701:85–90

Cumber AJ, Forrester JA, Foxwell BM, Ross WC, Thorpe PE (1985) Preparation of antibody-toxin conjugates. Methods Enzymol 112:207–225

Dellacherie E, Bonneaux F, Labrude P, Vigneron C (1983) Modification of human hemoglobin by covalent association with soluble dextran. Biochim Biophys Acta 749(1):106–114

Dellacherie E, Vigneron C (1991) Hemoglobin-based artificial blood: new polymeric derivatives of hemoglobin with low oxygen affinity. Int J Artif Organs 14(1):28–32

Doherty DH, Doyle MP, Curry SR, Vali RJ, Fattor TJ, Olson JS, Lemon DD (1998) Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat Biotechnol 16(7):672–676

Doyle MP, Apostol I, Kerwin BA (1999) Glutaraldehyde modification of recombinant human hemoglobin alters its hemodynamic properties. J Biol Chem 274(4):2583–2591

D’Agnillo F, Chang TM (1993) Cross-linked hemoglobin-superoxide dismutase-catalase scavenges oxygen-derived free radicals and prevents methemoglobin formation and iron release. Biomater Artif Cells Immobilization Biotechnol 21(5):609–621

D’Agnillo F, Chang TM (1998) Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat Biotechnol 16(7):667–671

Eich RF, Li T, Lemon DD, Doherty DH, Curry SR, Aitken JF, Mathews AJ, Johnson KA, Smith RD, Phillips GN Jr, Olson JS (1996) Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry 35(22):6976–6983

Eike JH, Palmer AF (2004) Oxidized mono-, di-, tri-, and polysaccharides as potential hemoglobin cross-linking reagents for the synthesis of high oxygen affinity artificial blood substitutes. Biotechnol Prog 20(3):953–962

Elmer J, Alam HB, Wilcox SR (2012) Hemoglobin-based oxygen carriers for hemorrhagic shock. Resuscitation 83(3):285–292

Epstein CJ, Anfinsen CB (1962) The reversible reduction of disulfide bonds in trypsin and ribonuclease coupled to carboxymethyl cellulose. J Biol Chem 237:2175–2179

Faggiano S, Ronda L, Bruno S, Jankevics H, Mozzarelli A (2010) Polymerized and polyethylene glycol-conjugated hemoglobins: a globin-based calibration curve for dynamic light scattering analysis. Anal Biochem 401(2):266–270

Fronticelli C, Bucci E, Razynska A, Sznajder J, Urbaitis B, Gryczynski Z (1990) Bovine hemoglobin pseudo-crosslinked with mono(3,5-dibromosalicyl)-fumarate. Eur J Biochem 193(2):331–336

Gourianov N, Kluger R (2003) Cross-linked bis-hemoglobins: connections and oxygen binding. J Am Chem Soc 125(36):10885–10892

Hai TT, Nelson D, Pereira D, Srnak A (1994) Diaspirin crosslinked hemoglobin (DCLHb) polymerization. Artif Cells Blood Substit Immobil Biotechnol 22(3):923–931

Hai TT, Pereira DE, Nelson DJ, Srnak A, Catarello J (1999) Polymerization of diaspirin cross-linked hemoglobin (DCLHb) with water-soluble, nonimmunogenic polyamide cross-linking agents. Bioconjug Chem 10(6):1013–1020

Harrington JP, Wollocko J, Kostecki E, Wollocko H (2011) Physicochemical characteristics of OxyVita hemoglobin, a zero-linked polymer: liquid and powder preparations. Artif Cells Blood Substit Immobil Biotechnol 39(1):12–18

Hsia CJ, Ma L (2012) A hemoglobin-based multifunctional therapeutic: polynitroxylated pegylated hemoglobin. Artif Organs 36(2):215–220

Hu T, Prabhakaran M, Acharya SA, Manjula BN (2005) Influence of the chemistry of conjugation of poly (ethylene glycol) to Hb on the oxygen binding and solution properties of the PEG-Hb conjugate. Biochem J 392(Pt 3):555–564

Hu T, Li D, Manjula BN, Acharya SA (2008) Autoxidation of the site-specifically PEGylated hemoglobins: role of the PEG chains and the sites of PEGylation in the autoxidation. Biochemistry 47(41):10981–10990

Hu D, Kluger R (2008) Functional cross-linked hemoglobin bis-tetramers: geometry and cooperativity. Biochemistry 47(47):12551–12561

Jahr JS, Akha AS, Holtby RJ (2012) Crosslinked, polymerized, and PEG-conjugated hemoglobin-based oxygen carriers: Clinical safety and efficacy of recent and current products. Curr Drug Discov Technol 9(3):158–165

Jia Y, Wood F, Menu P, Faivre B, Caron A, Alayash AI (2004) Oxygen binding and oxidation reactions of human hemoglobin conjugated to carboxylate dextran. Biochim Biophys Acta 1672(3):164–173

Jones MW, Strickland RA, Schumacher FF, Caddick S, Baker JR, Gibson MI, Haddleton DM (2012) Polymeric dibromomaleimides as extremely efficient disulfide bridging biconjugation and pegylation agents. J Am Chem Soc 134(3):1847–1852

Kaul DK, Hebbel RP (2000) Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest 106(3):411–420

Kaul DK, Liu XD, Zhang X, Ma L, Hsia CJ, Nagel RL (2006) Inhibition of sickle red cell adhesion and vasoocclusion in the microcirculation by antioxidants. Am J Physiol Heart Circ Physiol 291(1):H167–H175

Keipert PE, Olofsson C, Winslow RM (2008) Hemoglobin-based blood substitutes and risk of myocardial infarction and death. JAMA 300(11):1295–1296

Khan I, Dantsker D, Samuni U, Friedman AJ, Bonaventura C, Manjula B, Acharya SA, Friedman JM (2001) Beta 93 modified hemoglobin: kinetic and conformational consequences. Biochemistry 40(25):7581–7592

Klett D, Grandgeorge M, Dellacherie E (1992) Fixation of aldehydic dextrans onto human deoxyhemoglobin. Biopolymers 32(5):517–522

Kluger R, Zhang J (2003) Hemoglobin dendrimers: functional protein clusters. J Am Chem Soc 125(20):6070–6071

Li D, Manjula BN, Acharya AS (2006) Extension arm facilitated PEGylation of hemoglobin: correlation of the properties with the extent of PEGylation. Protein J 25(4):263–274

Li D, Manjula BN, Ho NT, Simplaceanu V, Ho C, Acharya AS (2007) Molecular aspects of the high oxygen affinity of non-hypertensive hexa pegylated hemoglobin, [(SP-PEG5 K)(6)-Hb]. Artif Cells Blood Substit Immobil Biotechnol 35(1):19–29

Li D, Hu T, Manjula BN, Acharya SA (2008) Non-conservative surface decoration of hemoglobin: influence of neutralization of positive charges at PEGylation sites on molecular and functional properties of PEGylated hemoglobin. Biochim Biophys Acta 1784(10):1395–1401

Lui FE, Kluger R (2009) Enhancing nitrite reductase activity of modified hemoglobin: bis-tetramers and their PEGylated derivatives. Biochemistry 48(50):11912–11919

MacDonald SL, Pepper DS (1994) Hemoglobin polymerization. Methods Enzymol 231:287–308

Mahaseth H, Vercellotti GM, Welch TE, Bowlin PR, Sonbol KM, Hsia CJ, Li M, Bischof JC, Hebbel RP, Belcher JD (2005) Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice. J Lab Clin Med 145(4):204–211

Manjula BN, Smith PK, Malavalli A, Acharya AS (1995) Intramolecular cross-linking of oxy hemoglobin by bis sulfosuccinimidyl suberate and sebacate: generation of cross-linked hemoglobin with reduced oxygen affinity. Artif Cells Blood Substit Immobil Biotechnol 23(3):311–318

Manjula BN, Malavalli A, Smith PK, Chan NL, Arnone A, Friedman JM, Acharya AS (2000) Cys-93-betabeta-succinimidophenyl polyethylene glycol 2000 hemoglobin A. Intramolecular cross bridging of hemoglobin outside the central cavity. J Biol Chem 275(8):5527–5534

Manjula BN, Tsai A, Upadhya R, Perumalsamy K, Smith PK, Malavalli A, Vandegriff K, Winslow RM, Intaglietta M, Prabhakaran M, Friedman JM, Acharya AS (2003) Site-specific PEGylation of hemoglobin at Cys-93(β): Correlation between the colligative properties of the PEGylated protein and the length of the conjugated PEG chain. Bioconjug Chem 14(2):464–472

Manjula BN, Tsai AG, Intaglietta M, Tsai CH, Ho C, Smith PK, Perumalsamy K, Kanika ND, Friedman JM, Acharya SA (2005) Conjugation of multiple copies of polyethylene glycol to hemoglobin facilitated through thiolation: influence on hemoglobin structure and function. Protein J 24(3):133–146

Matheson B, Kwansa HE, Bucci E, Rebel A, Koehler RC (2002) Vascular response to infusions of a nonextravasating hemoglobin polymer. J Appl Physiol 93(4):1479–1486

Marini M, Moore G, Fishman R, Jesse R, Medina F, Snell S et al (1989) A critical examination of the reaction of pyridoxal 5-phosphate with human hemoglobin A0. Biopolymers 28:2071–2083

McCarthy MR, Vandegriff KD, Winslow RM (2001) The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers. Biophys Chem 92(1–2):103–117

Menu P, Faivre B, Labrude P, Riffard P, Grandgeorge M, Vigneron C (1994) Human hemoglobin conjugated to carboxylate dextran as a potential red blood cell substitute. II–Pharmacotoxicological evaluation. Artif Cells Blood Substit Immobil Biotechnol 22(3):543–549

Miralles G, Verdié P, Puget K, Maurras A, Martinez J, Subra G (2013) Microwave-mediated reduction of disulfide bridges with supported (Tris(2- carboxyethyl)phosphine) as resin-bound reducing agent. ACS Comb Sci 15(4):169–173

Mito T, Nemoto M, Kwansa H, Sampei K, Habeeb M, Murphy SJ, Bucci E, Koehler RC (2009) Decreased damage from transient focal cerebral ischemia by transfusion of zero-link hemoglobin polymers in mouse. Stroke 40(1):278–284

Nho K, Linberg R, Johnson M, Gilbert C, Shorr R (1994) PEG-hemoglobin: an efficient oxygen-delivery system in the rat exchange transfusion and hypovolemic shock models. Artif Cells Blood Substit Immobil Biotechnol 22(3):795–803

Olofsson C, Nygårds EB, Ponzer S, Fagrell B, Przybelski R, Keipert PE, Winslow N, Winslow RM (2008) A randomized, single-blind, increasing dose safety trial of an oxygen-carrying plasma expander (Hemospan) administered to orthopaedic surgery patients with spinal anaesthesia. Transfus Med 18(1):28–39

Payne J (1973) Polymerization of proteins with glutaraldehyde Soluble molecular-weight markers. Biochem J 135:867–873

Portöro I, Kocsis L, Hermán P, Caccia D, Perrella M, Ronda L, Bruno S, Bettati S, Micalella C, Mozzarelli A, Varga A, Vas M, Lowe KC, Eke A (2008) Towards a novel haemoglobin-based oxygen carrier: Euro-PEG-Hb, physico-chemical properties, vasoactivity and renal filtration. Biochim Biophys Acta 1784(10):1402–1409

Quellec P, Léonard M, Grandgeorge M, Dellacherie E (1994) Human hemoglobin conjugated to carboxylate dextran as a potential red blood cell substitute. I. Further physico-chemical characterization. Artif Cells Blood Substit Immobil Biotechnol 22(3):669–676

Razack S, D’Agnillo F, Chang TM (1997) Crosslinked hemoglobin-superoxide dismutase-catalase scavenges free radicals in a rat model of intestinal ischemia-reperfusion injury. Artif Cells Blood Substit Immobil Biotechnol 25(1–2):181–192

Salazar Vázquez BY, Wettstein R, Cabrales P, Tsai AG, Intaglietta M (2008) Microvascular experimental evidence on the relative significance of restoring oxygen carrying capacity vs. blood viscosity in shock resuscitation. Biochim Biophys Act 1784(10):1421–1427

Sampei K, Ulatowski JA, Asano Y, Kwansa H, Bucci E, Koehler RC (2005) Role of nitric oxide scavenging in vascular response to cell-free hemoglobin transfusion. Am J Physiol Heart Circ Physiol 289(3):H1191–H1201

Savoca KV, Abuchowski A, van Es T, Davis FF, Palczuk NC (1979) Preparation of a non-immunogenic arginase by the covalent attachment of polyethylene glycol. Biochim Biophys Acta 578(1):47–53

Scatena R, Giardina B (2001) O-raffinose-polymerised haemoglobin. A biochemical and pharmacological profile of an oxygen carrier. Expert Opin Biol Ther 1(1):121–127

Scurtu F, Zolog O, Iacob B, Silaghi-Dumitrescu R. Hemoglobin-albumin cross-linking with disuccinimidyl suberate (DSS) and/or glutaraldehyde for blood substitutes. Artif Cells Nanomed Biotechnol. 2013 Jan 23. [Epub ahead of print]

Sriram K, Tsai AG, Cabrales P, Meng F, Acharya SA, Tartakovsky DM, Intaglietta M (2012) PEG-albumin supraplasma expansion is due to increased vessel wall shear stress induced by blood viscosity shear thinning. Am J Physiol Heart Circ Physiol 302(12):H2489–H2497

Styslinger TJ, Zhang N, Bhatt VS, Pettit N, Palmer AF, Wang PG (2012) Site-selective glycosylation of hemoglobin with variable molecular weight oligosaccharides: potential alternative to PEGylation. J Am Chem Soc 134(17):7507–7515

Tarasov E, Blaszak MM, LaMarre JM, Olsen KW (2007) Synthesis of a hemoglobin polymer containing antioxidant enzymes using complementary chemistry of maleimides and sulfhydryls. Artif Cells Blood Substit Immobil Biotechnol 35(1):31–43

Tsai AG, Friesenecker B, McCarthy M, Sakai H, Intaglietta M (1998) Plasma viscosity regulates capillary perfusion during extreme hemodilution in hamster skinfold model. Am J Physiol 275(6 Pt 2):H2170–H2180

Tsai AG, Intaglietta M (2002) The unusual properties of effective blood substitutes. Keio J Med 51(1):17–20

Tsai AG, Vandegriff KD, Intaglietta M, Winslow RM (2003) Targeted O2 delivery by low-P50 hemoglobin: a new basis for O2 therapeutics. Am J Physiol Heart Circ Physiol 285(4):H1411–H1419

Vandegriff KD, McCarthy M, Rohlfs RJ, Winslow RM (1997) Colloid osmotic properties of modified hemoglobins: chemically cross-linked versus polyethylene glycol surface-conjugated. Biophys Chem 69(1):23–30

Vandegriff KD, Malavalli A, Wooldridge J, Lohman J, Winslow RM (2003) MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion 43(4):509–516

Vandegriff KD, Young MA, Lohman J, Bellelli A, Samaja M, Malavalli A, Winslow RM (2008a) CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats. Br J Pharmacol 154(8):1649–1661

Vandegriff KD, Malavalli A, Mkrtchyan GM, Spann SN, Baker DA, Winslow RM (2008b) Sites of modification of hemospan, a poly (ethylene glycol)-modified human hemoglobin for use as an oxygen therapeutic. Bioconjug Chem 19(11):2163–2170

Vasseur-Godbillon C, Sahu SC, Domingues E, Fablet C, Giovannelli JL, Tam TC, Ho NT, Ho C, Marden MC, Baudin-Creuza V (2006) Recombinant hemoglobin βG83C-F41Y. FEBS J 273(1):230–241

Walder RY, Andracki ME, Walder JA (1994) Preparation of intramolecularly cross-linked hemoglobins. Methods Enzymol 231:274–280

Winslow RM (2000) αα-crosslinked hemoglobin: was failure predicted by preclinical testing? Vox Sang 79(1):1–20

Winslow RM (2003) Current status of blood substitute research: towards a new paradigm. J Intern Med 253(5):508–517

Winslow RM (2006) Current status of oxygen carriers (‘blood substitutes’): 2006. Vox Sang 91(2):102–110

Winslow RM (2008) Cell-free oxygen carriers: scientific foundations, clinical development, and new directions. Biochim Biophys Acta 1784(10):1382–1386

Wong JT (1988) Rightshifted dextran-hemoglobin as blood substitute. Biomater Artif Cells Artif Organs 16(1–3):237–245

Yabuki A, Yamaji K, Ohki H, Iwashita Y (1990) Characterization of a pyridoxalated hemoglobin-polyoxyethylene conjugate as a physiologic oxygen carrier. Transfusion 30(6):516–520

Young MA, Malavalli A, Winslow N, Vandegriff KD, Winslow RM (2007) Toxicity and hemodynamic effects after single dose administration of Mal PEG-hemoglobin (MP4) in rhesus monkeys. Transl Res 149(6):333–342

Zhang N, Palmer AF (2010) Polymerization of human hemoglobin using the crosslinker 1,11-bis(maleimido)triethylene glycol for use as an oxygen carrier. Biotechnol Prog 26(5):1481–1485

Titel: Design of Nonhypertensive Conjugated Hemoglobins as Novel Resuscitation Fluids
verfasst von: Seetharama A. Acharya
Marcos Intaglietta
Amy G. Tsai
Fantao Meng
Verlag: Springer Berlin Heidelberg
Buch: Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics
Print ISBN: 978-3-642-40716-1

Electronic ISBN: 978-3-642-40717-8

Copyright-Jahr: 2013
DOI: https://doi.org/10.1007/978-3-642-40717-8_11

Premium Partner

Marktübersichten

Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.

Zur Marktübersicht